Double-Blind Randomized Clinical Trial: Gluten versus Placebo Rechallenge in Patients with Lymphocytic Enteritis and Suspected Celiac Disease | PLOS ONE
![Evaluating Responses to Gluten Challenge: A Randomized, Double-Blind, 2-Dose Gluten Challenge Trial - Gastroenterology Evaluating Responses to Gluten Challenge: A Randomized, Double-Blind, 2-Dose Gluten Challenge Trial - Gastroenterology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/f5b5c3fc-d6ce-4e96-ad82-e72ef8e2f86b/fx1_lrg.jpg)
Evaluating Responses to Gluten Challenge: A Randomized, Double-Blind, 2-Dose Gluten Challenge Trial - Gastroenterology
Beyond Celiac - For an update on recent celiac disease research and progress on a treatment toward a cure, tune in to the latest episode of our podcast Celiac Straight Talk! Two
![Celiac Disease Foundation on Twitter: "What happens during each phase of a clinical trial? Learn more about clinical trials and potential future therapies for celiac disease here. https://t.co/AytoKOhCIc https://t.co/c0hl5r4W4x" / Twitter Celiac Disease Foundation on Twitter: "What happens during each phase of a clinical trial? Learn more about clinical trials and potential future therapies for celiac disease here. https://t.co/AytoKOhCIc https://t.co/c0hl5r4W4x" / Twitter](https://pbs.twimg.com/media/FRnFJFXWYAItxBm.jpg)
Celiac Disease Foundation on Twitter: "What happens during each phase of a clinical trial? Learn more about clinical trials and potential future therapies for celiac disease here. https://t.co/AytoKOhCIc https://t.co/c0hl5r4W4x" / Twitter
![ImmusanT Publishes Positive Data from Phase 1 Trials of its Celiac Disease Drug Nexvax2 - Drug Discovery and Development ImmusanT Publishes Positive Data from Phase 1 Trials of its Celiac Disease Drug Nexvax2 - Drug Discovery and Development](https://drugdiscoverytrends.com/wp-content/uploads/2019/10/celiac-disease.jpg)
ImmusanT Publishes Positive Data from Phase 1 Trials of its Celiac Disease Drug Nexvax2 - Drug Discovery and Development
![Beyond Celiac on Twitter: "The FDA released draft guidance about how celiac disease clinical trials should be conducted. Draft guidance is not binding, and undergoes a public comment period. The FDA may Beyond Celiac on Twitter: "The FDA released draft guidance about how celiac disease clinical trials should be conducted. Draft guidance is not binding, and undergoes a public comment period. The FDA may](https://pbs.twimg.com/media/FTxe3Q3WAAA8O82.png)